Evoke Pharma Inc (EVOK)
4.35
+0.05
(+1.16%)
USD |
NASDAQ |
Nov 14, 12:07
Evoke Pharma Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2014 | 0.00 |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Repligen Corp | -7.40M |
| Eli Lilly and Co | -4.005B |
| MEI Pharma Inc | 19.54M |
| Revance Therapeutics Inc | 23.29M |
| NovaBay Pharmaceuticals Inc | -0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.8206M |
| Cash from Financing (Quarterly) | 0.2957M |
| Free Cash Flow | -5.548M |
| Free Cash Flow Per Share (Quarterly) | -7.222 |
| Free Cash Flow to Equity (Quarterly) | -0.8206M |
| Free Cash Flow Yield | -357.3% |